Last update 21 Mar 2025

CCB-005

Overview

Basic Info

Drug Type
Gene therapy
Synonyms
CCB 005, CCB005
Target
COL5A1
Action
inhibitors
Mechanism
COL5A1 inhibitors(collagen type V alpha 1 chain inhibitors), Gene transference
Therapeutic Areas
Congenital DisordersSkin and Musculoskeletal DiseasesOther Diseases
Active Indication
Ehlers-Danlos Syndrome
Inactive Indication-
Originator Organization
Mayo ClinicMayo Clinic
Active Organization
Castle Creek Biosciences, Inc.Castle Creek Biosciences, Inc.Startup
Inactive Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with CCB-005
Login to view more data
100 Translational Medicine associated with CCB-005
Login to view more data
100 Patents (Medical) associated with CCB-005
Login to view more data
100 Deals associated with CCB-005
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Ehlers-Danlos SyndromeDiscovery
United States
Castle Creek Biosciences, Inc.Castle Creek Biosciences, Inc.Startup
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free